[Kanamycin in the treatment of suppurative-septic infections].
D055598:Chemical Phenomena; D002621:Chemistry; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects; D004927:Escherichia coli Infections / Q000188:drug therapy; D006801:Humans; D007239:Infections / Q000188:drug therapy*; D007612:Kanamycin / Q000009:adverse effects / Q000032:analysis / Q000096:biosynthesis / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D008970:Molecular Weight; D011512:Proteus Infections / Q000188:drug therapy; D012995:Solubility; D013203:Staphylococcal Infections / Q000188:drug therapy; D013492:Suppuration / Q000188:drug therapy*; D014570:Urologic Diseases / Q000188:drug therapy
D007612:Kanamycin
Kanamitsin v lechenii gnoĭno-spticheskikh infektsilĭ.